NEW YORK, May 19, 2011 /PRNewswire/ -- Springer Science+Business Media, a leading global scientific publisher of books and journals, and TEMIS, a leading provider of Semantic Content Enrichment solutions for the Enterprise, today announced they have agreed on a broad extension of their strategic collaboration on semantic enrichment and linking of content for the SpringerLink platform.
A global leader in Scientific, Technical and Medical publishing, Springer Science+Business Media operates SpringerLink, one of the world's largest distribution platforms for scientific eBooks and eJournals.
Springer and TEMIS have a long and successful track-record of joint work aimed at facilitating information access on the SpringerLink portal by offering intuitive navigational tools to customers searching for the scientific content most relevant to their topics of interest. At the core of this partnership, TEMIS's flagship Luxid(R) Content Enrichment Platform leverages a sophisticated combination of linguistic and statistical methods to calculate semantic relatedness among the millions of publications accessible on SpringerLink. This enables the automatic recommendation for each available article or book chapter of a selection of highly-relevant, semantically-related documents, without requiring specific editorial efforts.
The goal of the recent extension of the Springer-TEMIS partnership is to generalize this approach to link not only documents to each other, but also to concepts originating from structured domain-specific vocabularies and to key topics derived from the documents' content.
"At Springer, we are always working on making our content findable in a better and more efficient way. With Semantic Linking, we can offer our users powerful tools of discovery that make it so much easier to find relevant content," said Dr. Thomas Mager, Executive Vice President Publishing Product Development at Springer. "We are happy to extend our successful cooperation with TEMIS and start our new project, which will create a rich web of connectivity between all content items on SpringerLink."
The project reaffirms TEMIS' position as the leading vendor of Semantic Content Enrichment Solutions. "Springer clearly understands the current challenges and opportunities associated to digital publishing and the transformational role that Semantic Content Enrichment can play for SpringerLink. We are very excited to support Springer's strategic plans in this domain," explains Stefan Geissler, Managing Director of TEMIS Deutschland, and one of TEMIS founders. "The fact that TEMIS is able to deliver meaningful results on arbitrary scientific fields with subsecond response times proves the unparalleled adaptability of the TEMIS Luxid(R) Content Enrichment Platform."
Springer is a leading global scientific publisher of books and journals, delivering quality content through innovative information products and services. It publishes close to 500 academic and professional society journals. Springer is part of the publishing group Springer Science+Business Media. In the science, technology and medicine (STM) sector, the group publishes around 2,000 journals and more than 6,500 new books a year, as well as the largest STM eBook Collection worldwide. Springer has operations in about 20 countries in Europe, the USA, and Asia, and more than 5,000 employees.
TEMIS is the leading provider of Text Analytics-based content enrichment software, turning unstructured data into actionable knowledge, enabling advanced content analysis and strategic information discovery.
Its Content Enrichment solution Luxid(R) automatically associates value-added metadata to contents. Luxid(R) addresses the needs of publishers as well as Enterprises, enabling contents connection and information search optimization.
Founded in 2000, TEMIS operates in the United States, Canada, UK, France and Germany, and is represented worldwide through its network of certified partners.
TEMIS' innovative solutions have attracted the business of leading organizations such as AAAS, Agence France-Presse, BASF, Bayer Schering Pharma, BNA (Bureau of National Affairs), Editions Lefebvre-Sarrut, Elsevier, Merck Serono, Nature Publishing Group, Novartis, Philip Morris International, Sanofi-aventis, Simon & Schuster, Springer Science+Business Media, The McGraw-Hill Companies, and Thomson Reuters.